15. Intas Pharmaceuticals Limited
Number of Employees: 8,000
Intas Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Ahmedabad. It produces generic medications as well as contracts clinical research and production. It operates 18 production sites, 15 of which are in India and the remainder in the United Kingdom and Mexico. Intas has a presence in more than 85 countries and is expanding at a CAGR of over 22%.
Number of Employees: 9,000
Emcure Pharmaceuticals Limited is a multinational pharmaceutical firm based in Pune, India. Emcure's product line includes tablets, capsules, and injectables. Emcure Pharmaceuticals' product portfolio, which has a strong chronic and sub-chronic emphasis, includes all the key medicines and is the industry leader in fields including women's health, blood-related illnesses, HIV, anti-infectives, cardiac care, and vitamins. Emcure Pharmaceuticals has distribution channels and a network that reaches over 70 countries. In addition, the company has 14 production plants and 5 R&D centers. Emcure Pharmaceuticals Limited generated revenue of $730 million in FY 2022.
Number of Employees: 13,561
Piramal Enterprises Limited conducts operations in the financial services and pharmaceutical industries in India, North America, Europe, Japan, and other countries. Financial Services and Pharmaceuticals Manufacturing and Services are two of its operating segments. The business provides contract development and manufacturing services, such as drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations, as well as drugs for intrathecal spasticity management, inhalation and injectable anesthesia, injectable pain, antibiotics, and other medications.
Number of Employees: 13,900
Torrent Pharmaceuticals Limited is the main company of the Torrent Group and is one of the leading Pharma companies in India. The firm is among the leaders in the therapeutic area of cardiovascular, central nervous system, gastrointestinal, and women's healthcare. Torrent Pharmaceuticals Limited in India originally introduced the idea of specialty marketing. The company is also well-represented in cancer, anti-infectives, diabetology, and pain treatment categories. Additionally, Torrent Pharma has a significant global footprint that spans 40 nations, with activities in developed and rising areas such as the US, Europe, Brazil, and the rest of the globe. The company operates through its 12 fully-owned subsidiaries, having a presence in 40 countries. In 2022, the company's revenue was $1.1 billion.
Number of Employees: 14,000
Abbott India Limited, located in Mumbai, is a publicly traded corporation and a subsidiary of Abbott Capital India Limited. It has one of the quickest rates of growth among Indian pharmaceutical businesses. The business offers trustworthy, high-quality drugs in various therapeutic areas, such as women's health, gastroenterology, cardiology, metabolic disorders, central nervous system, pain management, pre-term labor, vitamins, sleeplessness, vaccinations, consumer health, etc. Thyronorm, Eptoin, Duphaston, Duphalac, Vertin, Udiliv, Heptral, Digene, Cremaffin, and Prothiaden are some of its well-known trademarks.
Number of Employees: 14,750
Biocon Limited (NSE:BIOCON.NS) makes drugs, therapeutic compounds, and herbal items. Generics, Novel Biologics, Biosimilars, and Research Services are among the company's segments. Its primary focus areas include diabetes, cancer, immunology, ophthalmology, and bone health issues. It also offers comprehensive services for the research, development, and manufacture of both small and large molecules. The company provides customer assistance in around 120 countries, including Europe and the US. INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb (Itolizumab), and KRABEVA (Bevacizumab) are some of Biocon's most important brands in India. The company's consolidated revenue grew 14% to $1.1 billion in FY22.
Number of Employees: 15,415
Glenmark Pharmaceuticals Limited develops, produces, and markets pharmaceutical products in India, North America, Latin America, Europe, Japan, and globally through its subsidiaries. In the therapeutic fields of dermatology, respiratory, and cancer, the firm offers both branded and generic formulations and different active pharmaceutical components. The company operates 14 production plants in Argentina, the Czech Republic, India, and the US. Numerous regulatory agencies inspect these facilities, such as the US-FDA, MHRA UK, and ANVISA Brazil. In addition, being a research-driven company, Glenmark Pharmaceuticals Limited has also made investments in special R&D facilities for international markets. Glenmark Pharmaceuticals Limited brought in $1.48 billion in sales in FY 2022.
Number of Employees: 17,000
Alkem Laboratories is a pharmaceutical company with international operations. The business creates, produces, and markets pharmaceutical and nutraceutical goods. It has built a strong market position in anti-infective, gastrointestinal, pain management, vitamins, minerals, and nutritional areas, as well as acute treatment. Branded Generics, Generic Drugs, API Nutraceuticals, and Biosimilars are among the company's product offerings. As of March 31, 2022, Alkem had 21 production facilities—19 in India and 2 in the US. Clavam, Pan 40, Taxim-O, Taxim-D, Taxim Injection, Gemcal, A to Z Tabs, Ondem, Xone, Sumo, Zocef, Pipzo, Swich, Xone XP, and Uprise D3 are some of its top brands.
Number of Employees: 17000
Established in 1990, Divi's Laboratories is a top producer of active pharmaceutical ingredients, exporting top-notch goods to over 95 nations. Europe accounts for most of the company's sales, followed by North America, India, and Asia. The business views investing in mergers and acquisitions as a possible part of its operational growth plan to boost its R&D, production, and marketing capabilities. In FY22, Divi's Laboratories generated $1.1 billion in revenue.
Number of Employees: 20,000
Lupin Limited develops, produces, distributes, and markets a wide range of biotechnology products, branded and generic formulations, and active pharmaceutical ingredients (APIs). Cardiovascular, asthma, diabetes management, pediatrics, central nervous system, gastroenterology, anti-infectives, nonsteroidal anti-inflammatory medications (NSAIDs), anti-TB, and cephalosporins are among its areas of specialization. With 18 production facilities, Lupin sells its goods in more than 100 nations. India, the US, Japan, Europe, South Africa, the Philippines, and Australia are key markets for the company. The Indian pharmaceutical firm Lupin Limited announced net revenues of $1.96 billion for the fiscal year 2022.
Click to continue reading and see Top 5 Pharmaceuticals Company in India.
Suggested articles:
Disclosure: None. Top 15 Pharmaceuticals Company in India is originally published on Insider Monkey.
